[Prolotherapy in chronic musculoskeletal disorders]

Virgilio S, García Martí S, Alfie V, Pichon-Riviere A, Augustovski F, Alcaraz A, Bardach A, Ciapponi A.
Record ID 32018001534
Original Title: Proloterapia en patologías musculoesqueléticas crónicas
Authors' recomendations: CONCLUSIONS Low-quality evidence suggests that in patients with chronic musculoskeletal conditions, prolotherapy could show less benefits in pain and function improvement, at short-term, when compared with placebo. Moderate-quality evidence suggests that adding dextrose prolotherapy to a physical exercise protocol, compared with placebo or a physical exercise protocol as a sole intervention, is beneficial in reducing pain and improving function at mid and long-term. The clinical practice guidelines about chronic back pain, tendinopathies, and knee arthrosis surveyed do not consider prolotherapy as a therapeutic alternative. Most health payers from high-income countries surveyed, do not cover prolotherapy for any chronic musculoskeletal condition, whereas Latin American health payers consulted do not mention covering this technology. No prolotherapy cost-effectiveness studies have been found in Argentina.
Project Status: Completed
Year Published: 2019
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Musculoskeletal Diseases
  • Prolotherapy
  • Musculoskeletal Pain
  • Tendinopathy
  • Osteoarthritis
  • Injections, Intra-Articular
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.